SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-008379
Filing Date
2015-11-06
Accepted
2015-11-05 18:15:42
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20150930-10q.htm 10-Q 885103
2 EX-31.1 ex-311xcertificationofprin.htm EX-31.1 12014
3 EX-31.2 ex-312xcertificationofprin.htm EX-31.2 12018
4 EX-32.1 ex-321xcertificationpursua.htm EX-32.1 11307
  Complete submission text file 0001628280-15-008379.txt   4319223

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgls-20150930.xml EX-101.INS 856890
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20150930.xsd EX-101.SCH 31869
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20150930_cal.xml EX-101.CAL 49107
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20150930_def.xml EX-101.DEF 146814
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20150930_lab.xml EX-101.LAB 430251
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20150930_pre.xml EX-101.PRE 245069
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 151201970
SIC: 2834 Pharmaceutical Preparations